BNP Paribas Financial Markets’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $249M | Sell |
399,847
-48,524
| -11% | -$33M | 0.09% | 193 |
|
|
2026
Q1 | $346M | Buy |
448,371
+7,527
| +2% | +$5.76M | 0.17% | 115 |
|
|
2025
Q4 | $340M | Sell |
440,844
-36,808
| -8% | -$25M | 0.15% | 119 |
|
|
2025
Q3 | $269M | Sell |
477,652
-46,706
| -9% | -$26.4M | 0.14% | 120 |
|
|
2025
Q2 | $275M | Sell |
524,358
-222,255
| -30% | -$124M | 0.16% | 114 |
|
|
2025
Q1 | $474M | Buy |
746,613
+207,017
| +38% | +$142M | 0.28% | 62 |
|
|
2024
Q4 | $384M | Buy |
539,596
+244,184
| +83% | +$205M | 0.22% | 80 |
|
|
2024
Q3 | $311M | Buy |
295,412
+48,721
| +20% | +$54.2M | 0.21% | 86 |
|
|
2024
Q2 | $259M | Buy |
246,691
+6,867
| +3% | +$6.66M | 0.21% | 95 |
|
|
2024
Q1 | $231M | Buy |
239,824
+24,286
| +11% | +$23.1M | 0.2% | 101 |
|
|
2023
Q4 | $189M | Buy |
215,538
+30,432
| +16% | +$25.1M | 0.21% | 95 |
|
|
2023
Q3 | $152M | Buy |
185,106
+33,903
| +22% | +$26.6M | 0.2% | 101 |
|
|
2023
Q2 | $109M | Buy |
151,203
+41,165
| +37% | +$31.7M | 0.14% | 146 |
|
|
2023
Q1 | $90.4M | Buy |
110,038
+9,640
| +10% | +$7.27M | 0.13% | 157 |
|
|
2022
Q4 | $72.4M | Buy |
100,398
+15,401
| +18% | +$11.4M | 0.11% | 211 |
|
|
2022
Q3 | $58.6M | Sell |
84,997
-7,260
| -8% | -$4.57M | 0.09% | 239 |
|
|
2022
Q2 | $54.5M | Buy |
92,257
+25,417
| +38% | +$16.5M | 0.09% | 261 |
|
|
2022
Q1 | $46.7M | Sell |
66,840
-16,543
| -20% | -$10.5M | 0.06% | 302 |
|
|
2021
Q4 | $52.7M | Buy |
83,383
+34,116
| +69% | +$21M | 0.08% | 282 |
|
|
2021
Q3 | $29.8M | Sell |
49,267
-31,315
| -39% | -$19.4M | 0.04% | 450 |
|
|
2021
Q2 | $45M | Buy |
80,582
+6,611
| +9% | +$3.35M | 0.06% | 350 |
|
|
2021
Q1 | $35M | Sell |
73,971
-5,035
| -6% | -$2.45M | 0.05% | 371 |
|
|
2020
Q4 | $38.2M | Sell |
79,006
-53,422
| -40% | -$28.8M | 0.07% | 279 |
|
|
2020
Q3 | $74.1M | Buy |
132,428
+61,981
| +88% | +$37.6M | 0.11% | 183 |
|
|
2020
Q2 | $43.9M | Sell |
70,447
-5,172
| -7% | -$2.94M | 0.08% | 234 |
|
|
2020
Q1 | $36.9M | Buy |
75,619
+32,005
| +73% | +$13.2M | 0.08% | 241 |
|
|
2019
Q4 | $16.4M | Sell |
43,614
-104,383
| -71% | -$35.1M | 0.03% | 573 |
|
|
2019
Q3 | $41.1M | Sell |
147,997
-36,503
| -20% | -$10.8M | 0.07% | 265 |
|
|
2019
Q2 | $57.7M | Buy |
184,500
+133,928
| +265% | +$44.6M | 0.12% | 192 |
|
|
2019
Q1 | $20.8M | Sell |
50,572
-202,439
| -80% | -$83.4M | 0.04% | 421 |
|
|
2018
Q4 | $94.5M | Sell |
253,011
-76,963
| -23% | -$28.2M | 0.22% | 97 |
|
|
2018
Q3 | $133M | Sell |
329,974
-13,129
| -4% | -$5M | 0.2% | 103 |
|
|
2018
Q2 | $118M | Sell |
343,103
-6,124
| -2% | -$1.92M | 0.2% | 103 |
|
|
2018
Q1 | $120M | Sell |
349,227
-146,503
| -30% | -$51M | 0.23% | 81 |
|
|
2017
Q4 | $186M | Buy |
495,730
+19,926
| +4% | +$8.07M | 0.33% | 55 |
|
|
2017
Q3 | $213M | Buy |
475,804
+50,627
| +12% | +$24.1M | 0.52% | 31 |
|
|
2017
Q2 | $209M | Sell |
425,177
-108,066
| -20% | -$47.3M | 0.63% | 20 |
|
|
2017
Q1 | $207M | Buy |
533,243
+465,801
| +691% | +$173M | 0.55% | 30 |
|
|
2016
Q4 | $24.8M | Sell |
67,442
-1,226
| -2% | -$466K | 0.12% | 155 |
|
|
2016
Q3 | $27.6M | Buy |
68,668
+27,576
| +67% | +$11.1M | 0.11% | 132 |
|
|
2016
Q2 | $14.4M | Sell |
41,092
-31,483
| -43% | -$12.1M | 0.06% | 219 |
|
|
2016
Q1 | $26.2M | Buy |
72,575
+14,285
| +25% | +$5.89M | 0.11% | 150 |
|
|
2015
Q4 | $31.6M | Buy |
58,290
+22,798
| +64% | +$12.4M | 0.08% | 204 |
|
|
2015
Q3 | $16.5M | Sell |
35,492
-10,222
| -22% | -$5.49M | 0.04% | 298 |
|
|
2015
Q2 | $23.3M | Sell |
45,714
-49,975
| -52% | -$24.4M | 0.07% | 176 |
|
|
2015
Q1 | $43.2M | Buy |
95,689
+10,158
| +12% | +$4.3M | 0.12% | 109 |
|
|
2014
Q4 | $35.1M | Sell |
85,531
-3,605
| -4% | -$1.42M | 0.12% | 134 |
|
|
2014
Q3 | $32.1M | Buy |
89,136
+33,004
| +59% | +$11.1M | 0.03% | 237 |
|
|
2014
Q2 | $15.9M | Sell |
56,132
-41,537
| -43% | -$12.3M | 0.01% | 300 |
|
|
2014
Q1 | $29M | Sell |
97,669
-63,684
| -39% | -$19.6M | 0.02% | 221 |
|
|
2013
Q4 | $44.4M | Buy |
161,353
+5,807
| +4% | +$1.67M | 0.03% | 180 |
|
|
2013
Q3 | $48.7M | Buy |
155,546
+88,949
| +134% | +$23.4M | 0.04% | 187 |
|
|
2013
Q2 | $15M | Buy |
+66,597
| New | +$15.5M | 0.01% | 271 |
|
Other funds holding REGN
VCM
VPM
N
BNP Paribas Financial Markets's REGN Position: Q2 2026 in Review
BNP Paribas Financial Markets reduced its Regeneron Pharmaceuticals (REGN) stake by 11% in Q2 2026, selling an estimated $33M and leaving 399,847 shares worth $249M. The position accounts for 0.09% of the portfolio, ranked #193.
BNP Paribas Financial Markets first reported a position in REGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $474M in Q1 2025. 1,085 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- BNP Paribas Financial Markets held 399,847 shares of Regeneron Pharmaceuticals worth $249M as of Q2 2026.
- BNP Paribas Financial Markets sold 48,524 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $33M.
- Regeneron Pharmaceuticals made up 0.09% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #193 holding.
- BNP Paribas Financial Markets first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- BNP Paribas Financial Markets's Regeneron Pharmaceuticals position peaked at $474M in Q1 2025.
- 1,085 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.